Viewing Study NCT00744367


Ignite Creation Date: 2025-12-25 @ 12:40 AM
Ignite Modification Date: 2025-12-25 @ 10:51 PM
Study NCT ID: NCT00744367
Status: COMPLETED
Last Update Posted: 2016-08-05
First Post: 2008-08-29
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
Sponsor: Hoffmann-La Roche
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2008-10
Start Date Type: None
Primary Completion Date: 2010-11
Primary Completion Date Type: ACTUAL
Completion Date: 2010-11
Completion Date Type: ACTUAL
First Submit Date: 2008-08-29
First Submit QC Date: None
Study First Post Date: 2008-09-01
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: 2016-07-28
Disp First Post Date Type: ESTIMATED
Last Update Submit Date: 2016-08-03
Last Update Post Date: 2016-08-05
Last Update Post Date Type: ESTIMATED